Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON
  1. Homepagina
  2. Aandelen
  3. Japan
  4. Japan Exchange
  5. Astellas Pharma Inc.
  6. Onderneming
    4503   JP3942400007

ASTELLAS PHARMA INC.

(4503)
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
Beroep
Logo Astellas Pharma Inc.
Astellas Pharma Inc. is gespecialiseerd in onderzoek, ontwikkeling, productie en marketing van farmaceutische producten. Producten zijn met name voor immuunziekten, infectieziekten, huidziekten, kanker en urologische aandoeningen.

De netto-omzet is geografisch als volgt verdeeld: Japan (28,8%), Noord- en Zuid-Amerika (34,5%) en overige (36,7%).

Aantal werknemers : 15 455 mensen.
Verkoop per activiteit
20202021Delta
Pharmaceutical1 300 840.00100%1 249 530.00100% -3.94%
JPY in miljoenen
Verkoop per regio
20202021Delta
United States443 455.0034.1%473 190.0037.9% +6.71%
Established Markets296 103.0022.8%293 156.0023.5% -1%
Japan345 402.0026.6%279 130.0022.3% -19.19%
International134 792.0010.4%111 113.008.9% -17.57%
Greater China60 367.004.6%59 300.004.7% -1.77%
Other20 725.001.6%33 639.002.7% +62.31%
JPY in miljoenen
Managers
Naam Titel Leeftijd Van
Kenji Yasukawa Executive Officer 61 2010
Naoki Okamura CFO, Representative Director & Vice President 59 2021
Yoshitsugu Shitaka Chief Scientific Officer - -
Fumiaki Sakurai Head-Business Administration & Compliance - -
Mamoru Sekiyama Independent Outside Director 72 2017
Hiroshi Kawabe Independent Outside Director 69 2019
Tatsuro Ishizuka Independent Outside Director 66 2019
Nobue Yasuda Manager-Accounting - -
Nobuaki Tanaka Senior Executive Officer & General Manager-Sales 54 -
Claudia Mitchell, Dr. Senior VP-Product & Portfolio Strategy - 2019
Bestuurders
Naam Titel Leeftijd Van
Yoshihiko Hatanaka Chairman 64 2018
Kenji Yasukawa Executive Officer 61 2010
Naoki Okamura CFO, Representative Director & Vice President 59 2021
Tomokazu Fujisawa General Manager-Finance & Accounting 63 2006
Hiroko Sakai Manager-Pharmaceutical Audit 61 2012
Noriyuki Uematsu Auditor 61 2016
Hiroo Sasaki Outside Director 65 2018
Mamoru Sekiyama Independent Outside Director 72 2017
Hiroshi Kawabe Independent Outside Director 69 2019
Tatsuro Ishizuka Independent Outside Director 66 2019
Aandeelhouders
NaamAandelen%
Nomura Asset Management Co., Ltd. 112 101 000 6,02%
Wellington Management Co. LLP 96 092 754 5,16%
Sumitomo Mitsui Trust Asset Management Co., Ltd. 63 322 700 3,40%
Nikko Asset Management Co., Ltd. 60 908 600 3,27%
Nippon Life Insurance Co. 53 036 000 2,85%
Daiwa Asset Management Co. Ltd. 52 197 382 2,80%
The Vanguard Group, Inc. 48 612 767 2,61%
Norges Bank Investment Management 30 885 860 1,66%
Mitsubishi UFJ Kokusai Asset Management Co., Ltd. 25 126 400 1,35%
Regents of the University of California 24 335 000 1,31%
Participaties
NaamAandelen%Totale waarde
CYTOKINETICS, INCORPORATED (CYTK) 2 040 816 2,43% 93 020 393 USD
FIBROGEN, INC. (FGEN) 4 968 367 5,36% 70 053 975 USD
ASTELLAS PHARMA INC. (4503) 1 020 800 0,055% 16 581 181 USD
HOKUYAKU TAKEYAMA HOLDINGS,INC. (3055) 1 199 819 4,92% 7 095 454 USD
ONCOLYS BIOPHARMA INC. (4588) 727 200 4,18% 3 334 299 USD
BRICKELL BIOTECH, INC. (BBI) 12 303 0,011% 2 817 USD
Markten en indexen
- First Section
- Nikkei 225 / Stoxx Asia Pacific 50
Beurscodes
- Bloomberg-code :  4503:JP
- Reuters Code :  4503.T
- Datastreamcode :  
Bedrijfsgegevens
Astellas Pharma Inc.
2-5-1 Nihonbashi-Honcho
JP-103-8411 Chuo-ku, Tokyo

Telefoon : +81 3 3244 3000
Fax :
Internet : http://www.astellas.com
Merkenportefeuille
In samenwerking metMijn merken op de beurs
Meer merken vanAstellas Pharma Inc.
Sector Farmaceutische producten - Andere
Verschil t.o.v. 1 jan (%)Kapitalisatie (M$)
ASTELLAS PHARMA INC.1.23%30 709
JOHNSON & JOHNSON-2.62%438 538
ROCHE HOLDING AG-3.53%323 214
PFIZER, INC.-9.33%300 513
ABBVIE INC.-0.14%239 035
NOVO NORDISK A/S-12.67%223 059
ELI LILLY AND COMPANY-11.28%222 160
MERCK & CO., INC.6.07%205 334
NOVARTIS AG1.47%199 080
ASTRAZENECA PLC0.63%184 423
BRISTOL-MYERS SQUIBB COMPANY3.80%143 655
SANOFI3.56%130 689
AMGEN INC.2.81%130 283
GLAXOSMITHKLINE PLC3.72%114 285
BAYER AG10.89%58 114
CHUGAI PHARMACEUTICAL CO., LTD-2.65%52 330
JIANGSU HENGRUI MEDICINE CO., LTD.-9.82%45 917
TAKEDA PHARMACEUTICAL COMPANY LIMITED5.36%45 059
DAIICHI SANKYO CO., LTD.-12.24%43 067
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY-18.30%19 969
YUNNAN BAIYAO GROUP CO.,LTD-5.64%19 962